(Q80787679)
Statements
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group (English)
James R Anderson
Stephen J Qualman
Sheri L Spunt
Lynette M Smith
Frederick B Ruymann
Sarah S Donaldson
David A Rodeberg
William M Crist